Device innovation or systemic risk management?—rethinking priorities in diabetic percutaneous coronary intervention
Cardiovascular Diagnosis and Therapy · 2026-06 · 16 (3) · 38-38
DOI: 10.21037/cdt-2026-0183 ↗Kurz gefasst
Editorial in der Zeitschrift Cardiovascular Diagnosis and Therapy, 2026-06. Verfasst von Ricardo Ortiz-Lozada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Hospital Universitario Clínico San Carlos, Madrid, Spain. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
results from a multicentre, randomised controlled trial.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Hospital Universitario Clínico San Carlos, Madrid, Spain.
- Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain.
ORCID-Profile: Pablo Salinas
Zitieren
APA
Ortiz-Lozada, R., & Salinas, P. (2026). Device innovation or systemic risk management?—rethinking priorities in diabetic percutaneous coronary intervention. Cardiovascular Diagnosis and Therapy, 16(3), 38-38. https://doi.org/10.21037/cdt-2026-0183
Vancouver
Ortiz-Lozada R, Salinas P. Device innovation or systemic risk management?—rethinking priorities in diabetic percutaneous coronary intervention. Cardiovascular Diagnosis and Therapy. 2026;16(3):38-38. doi:10.21037/cdt-2026-0183
BibTeX
@article{OrtizLozada2026,
author = {Ortiz-Lozada, Ricardo and Salinas, Pablo},
title = {Device innovation or systemic risk management?—rethinking priorities in diabetic percutaneous coronary intervention},
journal = {Cardiovascular Diagnosis and Therapy},
year = {2026},
volume = {16},
number = {3},
pages = {38--38},
doi = {10.21037/cdt-2026-0183}
}
EUVIMED